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Abstract
Melanopsin is found in only 2% of mouse retinal ganglion cells (RGCs), making these RGCs uniquely and directly photosen-
sitive. Given that the majority of RGCs die after axotomy and that grafting of a peripheral nerve to the eye provides a permissive
environment for axon regrowth, the present study examined the survival and axonal regrowth of melanopsin-containing RGCs in
mice. One month after optic nerve transection and grafting, RGCs with regrown axons were labeled from the grafts and retinae were
processed to visualize melanopsin and TUJ1. Melanopsin-positive and negative RGCs were counted and compared to axotomized
RGCs from ungrafted eyes and uninjured RGCs. Melanopsin-positive RGCs showed a 3-fold increase in survival rate compared to
non-melanopsin RGCs. Despite this enhanced survival, melanopsin-containing RGCs did not show increased axon regrowth into
nerve grafts.
 2004 Elsevier Ltd. All rights reserved.
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If the optic nerve of mature rodents is transected
close to the eye, half of the retinal ganglion cells (RGCs)
die by the end of the ﬁrst week (Berkelaar, Clarke,
Wang, Bray, & Aguayo, 1994; Robinson, 1994), and this
axotomy-induced death continues to the extent that
90% of RGCs die by one month (Berkelaar et al.,
1994; Cenni et al., 1996; Robinson, 1994; Villegaz-Pe´rez,
Vidal-Sanz, Bray, & Aguayo, 1988; Villegaz-Pe´rez, Vi-
dal-Sanz, Rasminsky, Bray, & Aguayo, 1993). Even
with this profound loss, axotomy-induced RGC death
is not total. A small percentage of RGCs show long-0042-6989/$ - see front matter  2004 Elsevier Ltd. All rights reserved.
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E-mail address: robin038@mc.duke.edu (G.A. Robinson).term survival (Cenni et al., 1996; Villegaz-Pe´rez et al.,
1993), yet the vital characteristics of these few cells have
not been fully elucidated.
Attachment of a peripheral nerve graft to the eye at
the cut optic nerve stump provides a permissive environ-
ment for RGC axons to regrow (Cui & Harvey, 2000;
Inoue, Hosokawa, Morigiwa, Ohashi, & Fukuda,
2002; Inoue, Sasaki, Hosokawa, & Fukuda, 2000; Rob-
inson & Madison, 2000; Thanos, Mey, & Wild, 1993;
Vidal-Sanz, Bray, Villegaz-Pe´rez, Thanos, & Aguayo,
1987; Villegaz-Pe´rez et al., 1988; Watanabe, Sawai, &
Fukuda, 1993), and has also been reported to reduce
axotomy-induced RGC death in rats, suggesting a
trophic eﬀect of the graft (Villegaz-Pe´rez et al., 1988).
Even with this more permissive regrowth environment
however, few RGCs that survive for one month regrow
axons into a graft.
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ﬁed that are directly light-sensitive and contain the puta-
tive photopigment melanopsin (Gooley, Lu, Chou,
Scammell, & Saper, 2001; Hattar, Liao, Takao, Berson,
& Yau, 2002; Provencio et al., 2000). These uniquely
photosensitive ganglion cells that appear to help regu-
late the circadian clock (Berson, Dunn, & Takao,
2002; Panda et al., 2002) and other irradiance-based
tasks (Hattar et al., 2003) account for only 2% of all
RGCs (Hattar et al., 2002). Given their unique charac-
teristics, we ﬁrst examined whether melanopsin-contain-
ing RGCs showed the same pattern of cell death after
optic nerve transection as non-melanopsin RGCs and
second, whether the capacity of melanopsin-containing
RGCs for axonal regrowth into a peripheral nerve graft
was the same as non-melanopsin-containing RGCs. Pre-
liminary results of these ﬁnding have been reported in
abstract form (Robinson & Madison, 2003).2. Materials and methods
2.1. Animals
All procedures were approved by the Veterans Aﬀairs
Medical Center animal use and care committee. C57BL/6
mice (male and female, 20–22 g) were deeply anesthe-
tized for all the following procedures with a mixture of
ketamine, xylazine, and acepromazine in normal
(0.9%) saline (respectively, 100, 6, and 1 mg/kg, i.p.).
In the present work, each processed retina often contrib-
uted to more than one data set (e.g., retrogradely labeled
RGCs from a graft combined with melanopsin immun-
ocytochemistry). Accordingly, the number of retinae
contributing to each data set is indicated in Results
rather than indicating the number of animals prepared.
2.2. Peripheral nerve grafting
A portion (approximately 15 mm) of the femoral
nerve from the left hindlimb was harvested using micro-
scissors to serve as an autologous graft. Using an intra-
orbital approach, the left optic nerve was exposed by
longitudinally opening the dural sheath (to prevent
damage to the blood supply) and transected approxi-
mately 0.5 mm from the eye using microscissors. The
trunk of the femoral nerve graft was trimmed and ap-
posed to the ocular stump of the optic nerve and then
attached by application of Tisseel VH ﬁbrin sealant
prepared according to the manufacturers instructions
(Baxter Healthcare Products, Glendale, CA). Prelimi-
nary experiments determined that the manufacturers
syringe delivery system was too large for the present
application, so the two components (sealer and activa-
tor) were each loaded into multiple sterile 1 cc syringes
with short 30G needles and stored at 80 C. Prior tosurgery, both components were placed in a 37 C water
bath until needed. After the sealant stiﬀened, the
remaining graft was ligated at it most distal point and
placed in a channel in the skull made between the orbit
and the left occipital bone. The retinal blood supply was
examined by fundoscopy at the end of the procedure
after pupil dilation using topical 1% cyclopentolate
hydrochloride (Alcon, Ft. Worth, TX). Eyes with a
damaged blood supply were excluded from the study.
All surgical procedures were performed by the same
investigator.
2.3. Retinal ganglion cell axotomy alone
Using the same approach described above, the optic
nerve was transected and sealed with ﬁbrin sealant with-
out a peripheral nerve graft.
2.4. Retrograde labeling of regenerating retinal ganglion
cells
One month after graft attachment to the eye, mice
were reanesthetized and the ligated, distal graft was
reexposed. The graft was transected 10 mm from the
eye and a 4% Fluoro-Gold solution (FG, Fluorochrome,
Denver, CO) in normal saline was applied to the cut
graft to label regenerated RGC axons. The surgical area
was then closed and the animal allowed to recover.
2.5. Retrograde labeling of control retinal ganglion cells
For preliminary experiments to determine the num-
ber of retinal ganglion cells in control retinae and the
distribution of TUJ1 immunoreactivity, 4% FG was ap-
plied to the cut optic nerve and the mice allowed to
recover.
2.6. Retinal processing
All animals were anesthetized with an overdose of
anesthetic three days after application of FG and then
perfused through the heart with 0.1 M phosphate-buﬀ-
ered saline (PBS, pH 7.4) followed by 4% paraformalde-
hyde in PBS. Retinae were dissected and prepared as
ﬂattened wholemounts, with four radially oriented cuts
in each retina and the superior pole of the retina was
identiﬁed. Wholemounts were postﬁxed for <1 h and
washed for at least 1 h in 0.1 M PBS.
2.7. Immunocytochemistry
Retinae were processed for melanopsin immunocyto-
chemistry using rabbit antiserum UF006 generated
against the N-terminus peptide of mouse melanopsin
(Panda et al., 2002) in combination with tyramide signal
ampliﬁcation and Alexa Fluor dyes (TSA kits #12 and
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Gold, anti-melanopsin and TUJ1 immunocytochemis-
tries, the choice of Alexaﬂuor dye was arbitrary as
both were used successfully. Brieﬂy, retinal whole-
mounts were incubated in 3% hydrogen peroxide in
PBS for 5 min to block non-speciﬁc peroxidase activity
and then washed extensively in PBS. Retinae were then
incubated in blocking buﬀer (TSA blocking reagent con-
taining 0.1% Triton-X in PBS) for 1 h, followed by incu-
bation in antiserum UF006 (1:5000 in blocking reagent)
for 72 h at 4 C with agitation. After extensive washing
in PBS, retinae were incubated in a horse radish peroxi-
dase (HRP)-conjugated anti-rabbit secondary antibody
(1:100 in blocking reagent) for 2 h. Wholemounts were
washed extensively and then incubated in ampliﬁcation
buﬀer containing 0.0015% hydrogen peroxide and tyra-
mide/Alexa Fluor 594 (1:100) for 15 min at room tem-
perature. No labeling was observed when primary
antibodies were omitted.
For TUJ1 immunocytochemistry, rabbit polyclonal
antibody PRB-435P (1:4000) recognizing neuronal type
III/beta tubulin (Covance Research Products, Berkeley,
CA), was used in the identical TSA protocol with labe-
ling by tyramide/Alexa Fluor 594 (1:300) for 30 min.
For RGC double-labeling, retinae were again incu-
bated in 3% hydrogen peroxide in PBS for 5 min to
block peroxidase activity, washed extensively in PBS,
and then incubated in the next primary antibody.
For combinations involving melanopsin staining,
anti-melanopsin immunoprocessing was always ﬁrst.
For combinations without melanopsin, anti-FG im-
munoprocessing was ﬁrst. Preliminary experiments
determined that double-labeling color separation could
be optimized when RGCs were processed for immuno-
cytochemistry using an antibody against FG (AB153,
rabbit polyclonal, Chemicon International, Temecula,
CA) in the identical TSA protocol described above with
the substitution of labeling by tyramide/Alexa Fluor 594
(1:500) for 15 min. At the end of all processing, the tis-
sue was extensively washed in PBS, mounted onto glass
slides, dehydrated through graded alcohols, cleared in
xylene and coverslipped with Cytoseal 60 (Richard-Al-
len Scientiﬁc, Kalamazoo, MI).
2.8. Retinal ganglion cell counts
RGCs were counted at a magniﬁcation of 400· using
a Zeiss Axiophot microscope equipped for ﬂuorescence.
Cells were identiﬁed using individual and composite ﬁl-
ter sets appropriate for Alexa Fluor 594, 488 and FG
(Chroma Technology, Brattleboro, VT). Two methods
were used to count RGCs. The ﬁrst method sampled
all RGCs within a ﬁxed area (e.g., 230 lm·230 lm at
400·, or the same box at 250·) at three eccentricities
in each quadrant (0.5, 1.5, and 2.5 mm from the optic
disk). The number of RGCs from these 12 regions/retinawas used to calculate the average density for each retina.
Total retinal area was determined by outlining the retina
using Stereo Investigator 2000 software (Microbright-
ﬁeld, Inc., Colchester, VT). Total RGCs per retina were
then determined by multiplying the density by the area.
This sampling method could not be used in grafted ret-
inae to count melanopsin-positive and regenerating
RGCs due to their small numbers, so a direct method
was used instead. These retinae were completely sur-
veyed using non-overlapping increments to determine
the total number of RGCs.
To examine if RGC death was inﬂuenced by location
within the retina, normal and axotomized RGC density
data from the most central location (0.5 mm from the
optic disk) was divided by data from the most peripheral
location from the disk (2.5 mm) for each quadrant and
expressed as a quotient.
2.9. Statistical analysis
Student t-tests for paired data were used to compare
distribution ratios within groups. Diﬀerences were con-
sidered statistically signiﬁcant when p<0.05. Analysis
of variance (using Student–Newman–Keuls post hoc
comparisons) was used to determine diﬀerences among
groups. Diﬀerences were considered statistically signiﬁ-
cant when F<0.05 and p<0.05.
2.10. Minipump implantation
All mice with peripheral nerve grafts received dorsal
subcutaneous minipumps (Alzet model 1007D, Durect
Corporation, Cupertino, CA) containing normal saline
at the time of initial surgery. All pumps were removed
7 days later. The pumps were implanted to provide base-
line data for future pharmacological manipulation of
RGC survival and axon regrowth using this model.3. Results
In agreement with previous reports of ganglion cell
counts in C57BL/6 mice (Inoue et al., 2000; Williams,
Strom, Rice, & Goldowitz, 1996), the distribution of
FG-labeled retinal ganglion cells in normal mouse ret-
ina was highest near the optic disk (4000 cells/mm2)
and least in the peripheral retina (Fig. 1A, 2600
cells/mm2) for an overall density of 3285±75 (N=5,
mean±SEM) representing 50,920±1161 RGCs per
retina. In contrast, the distribution of melanopsin-pos-
itive ganglion cells was reversed, with the highest den-
sity (90 cells/mm2) at the peripheral edge of the
retina and the lowest (25 cells/mm2) in the most cen-
tral retina (Fig. 2, upper panels) for an overall density
of 66±7 (N=6) representing 1023±104 RGCs per
retina.
Fig. 1. TUJ1 immunoreactivity co-localizes with retinal ganglion cells. (A) Ganglion cells containing yellow punctate FG (arrow) in a retinal
wholemount three days after application of the retrograde tracer to the cut optic nerve. (B) Red TUJ1 immunoreactivity using Alexa Fluor 594 co-
localized (arrow) to the same retrogradely labeled cells. TUJ1 staining was used to indicate all surviving ganglion cells without retrograde labeling.
Scale bar=25 lM.
Fig. 2. Melanopsin-positive retinal ganglion cells are reduced one
month after axotomy, but their retinal distribution is maintained. In
the normal eye melanopsin-positive ganglion cells are least dense in the
central retina and most dense in the peripheral retina. One month after
axotomy and placement of a nerve graft, melanopsin-positive cells are
reduced, but their diﬀerential distribution between the central and
peripheral retina is maintained. Scale bar=100 lM.
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TUJ1-immunocytochemistry (Fig. 1) revealed complete
overlap in RGCs between the two methods. This over-
lap allowed TUJ1 immunoreactivity to be used to indi-
cate the total number of surviving retinal ganglion
cells one month after axotomy in both grafted and un-
grafted retinae. In axotomized RGC preparations,
TUJ1-positive cytoplasmic processes of Mu¨ller glia were
also noted at the vitreal surface of wholemounts, but
these processes did not interfere with counting RGCs.
Ganglion cell density data revealed a signiﬁcant reduc-
tion to 396±27 (N=5) TUJ1-positive ganglion cells/
mm2 (for a total of 6132±455 RGCs per retina) one
month after axotomy alone and a similar reduction to
422±52 (N=4) TUJ1-positive ganglion cells/mm2 (for
a total of 6543±802 RGCs per retina) one month afteraxotomy and grafting (Fig. 3A). However, these reduc-
tions were not statistically diﬀerent from each other. The
extent of long-term axotomy-induced cell death de-
scribed here for all retinal ganglion cells is also in agree-
ment with other reports in rats and mice (Berkelaar
et al., 1994; Inoue et al., 2002; Robinson, 1994; Ville-
gaz-Pe´rez et al., 1988; Villegaz-Pe´rez et al., 1993).
Unexpectedly, melanopsin-positive ganglion cells sur-
vived to a signiﬁcantly greater degree than non-mela-
nopsin ganglion cells. Approximately 42% of the
original population of melanopsin-positive ganglion
cells survived after axotomy alone compared to only
12% of the original non-melanopsin ganglion cell pop-
ulation. In addition, the presence of a peripheral nerve
graft did not alter the relative percent survival between
the melanopsin-positive and non-melanopsin popula-
tions of axotomized ganglion cells (Fig. 4A). Propor-
tionally (Fig. 4B), melanopsin-positive ganglion cells
represented only 2% of all normal RGCs (1023±104
of the 50,920±1161 RGCs). After axotomy alone, their
proportional representation increased signiﬁcantly to
7% (431±50, N=5) of the ganglion cells that survived
(6132±455, N=5). A similar proportional increase in
representation was also seen in the nerve graft group,
with 6% (377±30, N=5) of the surviving ganglion
cells (6543±802, N=4) being melanopsin-positive.
While axotomy reduced the population of melanopsin-
positive ganglion cells by approximately half, their in-
creased density in the peripheral retina relative to the
central retina wasmaintained (Fig. 2). Based on immuno-
cytochemistry, melanopsin-positive ganglion cell bodies
appeared smaller after axotomy with less dendritic
branching (Fig. 2) both in the presence or absence of a
peripheral nerve graft.
The ratio of central to peripheral RGC densities was
examined to determine if RGC death was related to reti-
nal location. In normal retinae the ratio was 1.56±0.8
(N=5), indicating 156 RGCs per given area centrally
for every 100 RGCs in the peripheral retina. One month
after axotomy alone, the ratio (2.15±0.33, N=5) was
Fig. 3. Axotomy-induced retinal ganglion cell loss and axonal regrowth after nerve graft attachment. (A) Attachment of a femoral nerve graft to the
eye did not signiﬁcantly alter the profound ganglion cell death on month after axotomy. The mean density of ganglion cells was similarly reduced in
grafted and non-grafted retinae. (B) Compared to all ganglion cells (100%), the proportion with axonal regrowth into a peripheral nerve graft was
only 0.5%. (C) Among the subpopulation of surviving ganglion cells demonstrating axonal regrowth (100%) only 5.1% were melanopsin-positive.
Bars in A=SEM, in B, C=SD.
Fig. 4. The proportional survival of melanopsin-positive retinal ganglion cells compared to non-melanopsin ganglion cells after axotomy.
(A) Axotomy induced the loss of both types of ganglion cells at one month, but signiﬁcantly more melanopsin-positive ganglion cells survived at one
month (37% with or 42% without a nerve graft) compared to non-melanopsin ganglion cells (12% with or 11% without a nerve graft).
Asterisks denote diﬀerences at the p<0.05 level between melanopsin and non-melanopsin ganglion cells with and without nerve grafting using
ANOVA and post hoc t-tests. The proportion of RGCs with axon regrowth (a subset of the 1 month axotomy+graft data) was not signiﬁcantly
diﬀerent between melanopsin and non-melanopsin cell types (t-test). (B) The increased survival of melanopsin-positive ganglion cells led to a
signiﬁcant increase in their proportional representation among ganglion cells after axotomy: from 2% of normal RGCs to approximately 6% and
7% (grafted and ungrafted) of axotomized RGCs. Asterisk denotes diﬀerence at the p<0.05 level between the proportions of melanopsin-positive
RGCs in normal and experimental retinae using ANOVA and post hoc t-tests. Bars=SD.
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death was proportional across the retina. Similarly, the
ratio for melanopsin RGCs in the normal retina was
0.54±0.08 (N=5), and was not signiﬁcantly diﬀerent
one month after axotomy (0.61±0.08, N=4).
After axotomy, few of the surviving population of
retinal ganglion cells regrew axons into a peripheral
nerve graft. Only 232±78 (N=5) ganglion cells were ret-
rogradely-labeled (e.g., Fig. 5A) from the nerve grafts
one month after attachment. Proportionally (Fig. 3B),
this represents only 0.5% of the normal retinal ganglioncell population. When regenerating melanopsin-positive
ganglion cells (e.g., Fig. 5B) are normalized to all regen-
erating RGCs (Fig. 3C), the 12±5 ganglion cells per ret-
ina represent only 5% of the regenerating population.4. Discussion
We have examined the ability of mouse retinal gan-
glion cells containing the putative photopigment mela-
nopsin to survive axotomy and regrow an axon into a
Fig. 5. Melanopsin-positive and non-melanopsin retinal ganglion cells regrow axons into a peripheral nerve graft. (A) One month after graft
attachment to the eye, regenerating axons were labeled from the graft with FG and the retinal wholemount was processed for green anti-FG
immunoreactivity using Alexa Fluor 488 (arrow). Following processing for red anti-melanopsin immunoreactivity using Alexa Fluor 594 (B), the
proportion of regenerating ganglion cells that were also melanopsin-positive (arrow) was assessed (C). Scale bar=25 lM.
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this small subset of ganglion cells is less sensitive to axo-
tomy-induced cell death than the rest of the ganglion cell
population, and (2) that this increase in survival is not
matched by an increased ability to regrow axons into
the permissive environment of a peripheral nerve graft.
Axotomy-induced death of mature rodent retinal
ganglion cells has been well documented. Even though
most mouse and rat ganglion cells die after optic nerve
transection (Berkelaar et al., 1994; Cenni et al., 1996;
Robinson, 1994; Villegaz-Pe´rez et al., 1988; Villegaz-
Pe´rez et al., 1993), ganglion cells do not all die at the
same time. Half of these cells die rapidly within one
week of axotomy (Berkelaar et al., 1994; Robinson,
1994), with a small percentage of viable ganglion cells
persisting even months after the injury (Cenni et al.,
1996; Villegaz-Pe´rez et al., 1993).
Given that retinal ganglion cells are a diverse group
according to anatomical and physiological classiﬁcation
schemes (e.g., Boycott & Wa¨ssle, 1974; Fukuda, 1977),
the critical features of those that are injury-resistant
are unknown. Previous characterizations of injury-
resistantRGCs have associated themwith increased cyto-
chrome oxidase activity (von Bussmann, Gary, & Jen,
1993) as well as maintained expression of heat shock
protein 27 (Krueger-Naug, Emsley, Myers, Currie, &
Clarke, 2002) and transcription factor c-Jun (Robinson,
1994). Whether the surviving mouse melanopsin-con-
taining RGCs also share these other features of injury-
resistant RGCs is unknown. Recent work in the mouse
has shown non-uniform immediate early gene expres-
sion in melanopsin-positive RGCs (Semo, Lupi, Peirson,
Butler, & Foster, 2003), suggesting heterogeneity even
among this small population of RGCs.
The unique anatomy/physiology of melanopsin-con-
taining RGCs may contribute to their increased sur-
vival: the putative photopigment confers intrinsic
photosensitivity that is provided through unusually
large, yet sparsely branching dendritic ﬁelds (Bersonet al., 2002). Conversely, the axotomy-induced death
of half of the melanopsin-positive population suggests
that melanopsin is unlikely to be the sole survival factor.
Diﬀerential survival among melanopsin-positive RGCs
could be reﬂected in the two anatomically-deﬁned types
of these RGCs based on dendritic stratiﬁcation (Bel-
enky, Smeraski, Provencio, Sollars, & Pickard, 2003),
diﬀerences in immediate early gene expression (Semo
et al., 2003), or on an altered relationship between mela-
nopsin and pituitary adenyl cyclase-activating polypep-
tide, a neurotransmitter of the retinohypothalamic
tract that can be co-expressed in these RGCs (Hannibal,
Hindersson, Knudsen, Georg, & Fahrenkrug, 2002).
Interestingly, we observed that the vitreal cytoplas-
mic processes of Mu¨ller glia were labeled by the neuronal
beta III/tubulin marker TUJ1 only after RGC axotomy
(data not shown). Our data analysis using retinal whole-
mounts allowed us to negate this problem by focusing
through these processes onto TUJ1-positive cells within
the ganglion cell layer for counting non-melanopsin
RGCs, but the possibility remains that other cells in that
layer (i.e., normally TUJ1-negative displaced amacrine
cells) may also have become TUJ1-positive as a result
of retinal remodeling. Although we have no evidence
to support this change, the calculation of 12% surviv-
ing non-melanopsin RGCs after axotomy could be an
overestimate. The observed TUJ1-positive endfeet mir-
ror recent reports of Mu¨ller cell outgrowth associated
with retinal reattachment (Fisher & Lewis, 2003 for re-
view). Mu¨ller glia are known to provide neuroprotection
in the form of growth factors and antioxidants after
retinal injury (Garcia & Vecino, 2003). A possible expla-
nation for the preferential survival of some melanopsin-
containing RGCs is that they may be more sensitive to
the trophic factors provided by activated Mu¨ller glia
than non-melanopsin RGCs. From an evolutionary per-
spective of opsins, mouse melanopsin is most closely re-
lated to invertebrate opsins (Provencio, Jiang, De Grip,
Hayes, & Rollag, 1998). Melanopsin within this class of
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tinct class of RGC that is more injury-resistant (or in the
case of Mu¨ller glia-derived support, more responsive)
than RGCs that are not intrinsically photosensitive.
If RGC death were to occur in the central retina more
than in the peripheral retina, then the increased survival
of melanopsin-containing RGCs reported here might be
explained by diﬀerences in the retinal distribution of
non-melanopsin (highest density in the central retina)
and melanopsin RGCs (highest density in the peripheral
retina). Villegaz-Pe´rez et al. (1993) examined distribu-
tion-related RGC death in the rat and found no diﬀer-
ence in proportional RGC death one month after
axotomy. Similarly, we found no such diﬀerence in the
mouse when all RGCs were considered together or for
just the melanopsin-positive subpopulation.
In neonatal rodents, supernumerary RGCs undergo
naturally-occurring cell death and they are more suscep-
tible than mature RGCs to axotomy-induced cell death
(Bonfanti et al., 1996). Whether neonatal melanopsin-
containing RGCs are as susceptible to injury as the rest
of the RGC population and to what extent, if any, they
undergo naturally-occurring cell death remains to be
determined. Even without injury, 2% of the entire
RGC population dies monthly in the mouse resulting
in a 40% loss of ganglion cells over a lifetime (Neufeld
& Gachie, 2003). A similar loss (36%) of the melanop-
sin RGC population has been reported in old mice
(Semo et al., 2003), suggesting that they are equally sus-
ceptible as the rest of the ganglion cell population to this
type of long-term attrition.
The capacity for axotomized RGCs to regrow axons
into a conducive environment has also been well docu-
mented. While only a small percentage of RGCs survive
axotomy, an even smaller percentage of RGCs that sur-
vive the injury regrow axons into the permissive envi-
ronment of a peripheral nerve graft (Cui & Harvey,
2000; Inoue et al., 2002; Inoue et al., 2000; Robinson
& Madison, 2000; Thanos et al., 1993; Vidal-Sanz
et al., 1987; Villegaz-Pe´rez et al., 1988; Watanabe et
al., 1993). Again, characterizations of these regenerating
ganglion cells have not identiﬁed a speciﬁc cell type
(Robinson, 1995; Watanabe et al., 1993). In the rat,
quantitative studies using a variety of identiﬁcation
methods and strains have shown up to 9.5% of RGCs
can regrow axons into a graft (Robinson & Madison,
2000; Thanos et al., 1993; Vidal-Sanz et al., 1987; Ville-
gaz-Pe´rez et al., 1988). Compared to the rat, less robust
axonal regeneration is demonstrated here in the mouse,
with an average of 232 RGCs (0.5% of the total popula-
tion) per retina. This number of regenerating mouse
RGCs is slightly higher than the 0.1–0.3% reported by
other groups using the same model system (Cui & Har-
vey, 2000; Inoue et al., 2002; Inoue et al., 2000). Our
previous work with ﬁbrin glue in the rat suggested a pos-
itive inﬂuence of ﬁbrin glue on regenerating RGCs com-pared to direct suture attachment of the peripheral nerve
graft (Robinson & Madison, 2000). This diﬀerence in
grafting technique may also explain our slightly in-
creased number of regenerating mouse RGCs.
The lack of correlation shown here between the
capacity of RGC survival and subsequent ability to re-
grow axons into a nerve graft has also been previously
demonstrated in the mouse by overexpressing the anti-
apoptotic gene Bcl-2 (Inoue et al., 2002). Overexpression
of this gene rescued 65% of the RGC population from
axotomy-induced cell death, but the surviving RGCs
showed even less robust axon regrowth into a nerve
graft than wild-type controls (Inoue et al., 2002).
In the present study, no diﬀerence was seen in the
number of viable RGCs remaining one month after axo-
tomy with or without the placement of a nerve graft (Fig.
3A). At the same time point in the rat, Villegaz-Pe´rez
et al. (1988) suggested that graft placement increased
the number of presumed ganglion cells by 62%. The
lack of a graft eﬀect in the mouse may be attributable
to the more precise RGC identiﬁcation methods used
here and/or species diﬀerences between the two studies.
Variation in the number and distribution of melanop-
sin-positive ganglion cells does appear to be species-spe-
ciﬁc. For the C57BL/6 mouse, we concur with Belenky
et al. (2003) that these cells are distributed evenly
between dorsal and ventral retina and add the observa-
tion of a peripheral bias in cell density compared with
the central retina; a distribution that is maintained after
axotomy (Fig. 2). In the Wistar rat however, these cells
were preferentially found in the dorsal retina compared
to the ventral retina (Hannibal et al., 2002), while the re-
verse distribution was recently described in the Mongo-
lian gerbil (Fite, Blanchard, & Bengston, 2003).
Further work will be necessary to determine if the in-
creased survival of melanopsin-containing RGCs is re-
lated to their unique photosensitive ability among
RGCs. The enhanced survival of RGCs after Bcl-2 over-
expression is attributed to the inhibition of downstream
caspases in the apoptotic cascade (Inoue et al., 2002). It
would be interesting to know if the same mechanisms
apply to melanopsin-containing RGCs. Whatever the
exact mechanism of enhanced survival is, it is clear that
additional interventions will be necessary to enhance ax-
onal regrowth in surviving RGCs.Acknowledgments
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